C12N 2770/20062
By genetic engineering
Official title: by genetic engineering
C12N2770/20062 (By genetic engineering) appears on 17 US grants and 35 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 35
- Assignees
- 34
- Inventors
- 77
- Latest grant
- 27 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 2 | 1 |
| 2009 | 1 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 4 |
| 2018 | 2 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 2 | 1 |
| 2022 | 2 | 1 |
| 2023 | 0 | 6 |
| 2024 | 1 | 3 |
| 2025 | 2 | 6 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Particles, DNA and RNA27 Jan 2026US 12,533,406 B2Novoscope IP Limited
- Attenuated IBV with extended cell culture and tissue tropism2 Sep 2025US 12,403,191 B2Boehringer Ingelheim Vetmedica GmbH
- Viral preparations and methods for treating and modulating mitochondrial effects of coronavirus infections13 May 2025US 12,297,460 B1
- Modulation of replicative fitness by deoptimization of synonymous codons17 Sep 2024US 12,090,197 B2The Government of the USA, as represented by the Secretary, Department of Health and Human Services
- Modulation of replicative fitness by deoptimization of synonymous codons15 Nov 2022US 11,497,803 B2The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
- Treatment using a one-to-stop attenuated sars-cov-2 virus7 May 2026US 2026/0124293 A1Institut FüR Virologie Und Immunologie (Ivi)
- Live-attenuated sars-cov-2 vaccine23 Oct 2025US 2025/0325653 A1The U.S.A., as represented by the Secretary, Department of Health and Human Services
- Viral preparations and methods for treating and modulating mitochondrial effects of coronavirus infections.23 Oct 2025US 2025/0327038 A1
- Viral preparations and methods for treating and modulating mitochondrial effects of coronavirus infections.23 Oct 2025US 2025/0327039 A1
- One-to-stop attenuated sars-cov-2 virus25 Sep 2025US 2025/0295757 A1Institut FüR Virologie Und Immunologie (Ivi)
Most cited
By later US patents
- Coronavirus20US 10,130,701 B2The Pirbright Institute · 2018
- Modulation of replicative fitness by deoptimization of synonymous codons20US 8,846,051 B2The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · 2014
- Modulation of replicative fitness by deoptimization of synonymous codons4US 10,695,414 B2The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services, Center for Disease Control and Prevention · 2020
- Vaccine against infectious bronchitis virus2US 11,065,328 B22021
- SARS vaccine compositions and methods of making and using them2US 8,506,968 B2Eli Lilly and Company · 2013